https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112077/
It looks like those receiving Prednisolone or other steroid treatment and who start developing type-2 diabetes may need different treatment and benefit from different test regime.
The main takeaways from this for me were that
*Steroids can reduce sensitivity of insulin recep tors.
* treatment with metformin is possibly not a good idea. Exenatide was mooted as an option.
*Post-prandial spikes rather than fasting levels are most affected hence HbA1c and fasting tests are not the best indiactors.
*Insulin therapy (temporary until steroids are discontinued) may be best BUT standard dosing guidelines are inappropriate and may cause nighttime hypos.
And, as with most things, early identification of a problem is best. This gibes with most practical, one size fits all, treatment regimes: wait and see with std thresholds, followed by standard drug prescribing on a linear progression.
The article has sections covering different groups such as transplantees that may receive steroid treatment.
It looks like those receiving Prednisolone or other steroid treatment and who start developing type-2 diabetes may need different treatment and benefit from different test regime.
The main takeaways from this for me were that
*Steroids can reduce sensitivity of insulin recep tors.
* treatment with metformin is possibly not a good idea. Exenatide was mooted as an option.
*Post-prandial spikes rather than fasting levels are most affected hence HbA1c and fasting tests are not the best indiactors.
*Insulin therapy (temporary until steroids are discontinued) may be best BUT standard dosing guidelines are inappropriate and may cause nighttime hypos.
And, as with most things, early identification of a problem is best. This gibes with most practical, one size fits all, treatment regimes: wait and see with std thresholds, followed by standard drug prescribing on a linear progression.
The article has sections covering different groups such as transplantees that may receive steroid treatment.